HONG KONG -- A third dose of Sinovac's COVID vaccine does not provide sufficient protection against the omicron variant, new research reveals, contradicting the Chinese vaccine maker's pronouncement that it does.
COVID vaccines
Sinovac booster insufficient against omicron, study shows
China COVID vaccine fails to produce enough antibodies: Hong Kong universities
A healthcare worker and Sinovac vaccine recipient in Jakarta, Indonesia, on Dec. 14. Sinovac says that 94% of those who receive three doses of its vaccine generate enough neutralizing antibodies to protect against the omicron variant. © Reuters
Read Next
Latest on COVID vaccines
